Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 4/20 | 0.47 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.47 |
| ▸ | TLR2 | O60603 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.41 |
| ▸ | PPARG | P37231 | 6/20 | 0.41 |
| ▸ | PPARD | Q03181 | 6/20 | 0.41 |
| ▸ | PPARA | Q07869 | 6/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11307106 | 0.91 | LPAR1 (0.58) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL2759395 | 0.89 | LPAR1 (0.36) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL501728 | 0.87 | LPAR1 (0.54) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL9479089 | 0.87 | LPAR1 (0.54) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL9479413 | 0.87 | LPAR1 (0.54) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL9479653 | 0.87 | LPAR1 (0.54) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL9477400 | 0.87 | LPAR1 (0.54) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL21935885 | 0.87 | LPAR1 (0.35) | LPAR1LPAR3PLA2G2CTLR2LPAR2 | |
| SCHEMBL2951082 | 0.84 | PLA2G2C (0.46) | PLA2G2CTLR2PLA2G4BAKR1B1GPR84 | |
| SCHEMBL9629682 | 0.84 | USP2 (0.50) | PLA2G2CTLR2PLA2G4BAKR1B1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233468-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | LPAR1 191/4885LPAR3 201/4885PLA2G2C 291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.